tolazoline has been researched along with Pancreatic Diseases in 2 studies
Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.
Pancreatic Diseases: Pathological processes of the PANCREAS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmarsow, R | 1 |
| Czembirek, H | 1 |
1 trial available for tolazoline and Pancreatic Diseases
| Article | Year |
|---|---|
[Pharmacoangiography of the pancreas (author's transl)].
Topics: Angiography; Angiotensin II; Celiac Artery; Clinical Trials as Topic; Epinephrine; Humans; Injection | 1976 |
1 other study available for tolazoline and Pancreatic Diseases
| Article | Year |
|---|---|
[The pancreatographic effect during pharmacoangiography of the pancreas following the administration of glucagon (author's transl)].
Topics: Adult; Aged; Amylases; Angiography; Clinical Enzyme Tests; Diagnosis, Differential; Female; Glucagon | 1976 |